Journal
JOURNAL OF IMMUNOLOGY
Volume 181, Issue 2, Pages 1012-1018Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.2.1012
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01-RR00032, M01 RR000032] Funding Source: Medline
- NIAMS NIH HHS [AR42476, R01 AR033062, P01 AR049084, R01 AR042476, AR33062, P01-AR49084] Funding Source: Medline
Ask authors/readers for more resources
TNF ligand superfamily member 13B (B lymphocyte stimulator (BLyS), B cell activating factor (BAFF)) promotes primary B cell proliferation and Ig production. While the soluble form of BLyS/BAFF is thought to be the primary biologically active form, little is known about the regulation of its cleavage and processing. We provide evidence that Fc gamma receptor cross-linking triggers a rapid release of soluble, biologically active BLyS/BAFF from myeloid cells. Surprisingly, this function is primarily mediated by Fc gamma RI, but not Fc gamma RIIa as defined by specific mAb, and can be initiated by both IgG and C reactive protein as ligands. The generation of a B cell proliferation and survival factor by both innate and adaptive immune opsonins through engagement of an Fey receptor, which can also enhance Ag uptake and presentation, provides a unique opportunity to facilitate Ab production. These results provide a mechanism by which Fc gamma receptors can elevate circulating BLyS levels and promote autoantibody production in immune complex-mediated autoimmune diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available